Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» antivirals
antivirals
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
CNBC
Pfizer
Paxlovid
COVID-19
FDA
antivirals
Flag link:
Biotech launched during Covid — for Covid — looks for strategic alternatives after antiviral fails PhII trial
Biotech launched during Covid — for Covid — looks for strategic alternatives after antiviral fails PhII trial
Endpoints
Pardes Biosciences
antivirals
COVID-19
Flag link:
FDA adcomm votes in favor of Pfizer's Covid-19 pill Paxlovid
FDA adcomm votes in favor of Pfizer's Covid-19 pill Paxlovid
Endpoints
FDA
Pfizer
Paxlovid
antivirals
COVID-19
Flag link:
FDA staff report says data shows Pfizer’s Covid treatment Paxlovid is effective in high-risk adults
FDA staff report says data shows Pfizer’s Covid treatment Paxlovid is effective in high-risk adults
CNBC
Pfizer
Paxlovid
COVID-19
FDA
antivirals
Flag link:
Merck asks EMA to reevaluate rejected Covid-19 antiviral
Merck asks EMA to reevaluate rejected Covid-19 antiviral
Endpoints
Merck
Europe
EMA
COVID-19
Lagevrio
molnupiravir
antivirals
Flag link:
Merck pill linked to new mutations, study says
Merck pill linked to new mutations, study says
Fierce Pharma
Merck
antivirals
COVID-19
Lagevrio
Flag link:
Gilead nixes Matinas oral COVID-19 antiviral to focus on late-phase internal program
Gilead nixes Matinas oral COVID-19 antiviral to focus on late-phase internal program
Fierce Biotech
Gilead Sciences
Matinas BioPharma
COVID-19
antivirals
Flag link:
Pfizer's search for Paxlovid's COVID-busting sibling leads to low-profile antiviral biotech
Pfizer's search for Paxlovid's COVID-busting sibling leads to low-profile antiviral biotech
Fierce Biotech
Pfizer
Paxlovid
COVID-19
antivirals
Flag link:
Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck
Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck
Fierce Pharma
Shionogi
COVID-19
antivirals
Japan
Flag link:
FDA Cites ‘Uncertainties’ in Veru's COVID-19 Antiviral Data Ahead of Adcomm
FDA Cites ‘Uncertainties’ in Veru's COVID-19 Antiviral Data Ahead of Adcomm
BioSpace
Veru
FDA
antivirals
COVID-19
Flag link:
FDA chief stands by Paxlovid nod amid discussion on 'rebound' cases
FDA chief stands by Paxlovid nod amid discussion on 'rebound' cases
Fierce Pharma
Pfizer
Paxlovid
antivirals
COVID-19
FDA
Robert Califf
Flag link:
Siga nabs $10.7M from the US government in deal for its monkeypox antiviral
Siga nabs $10.7M from the US government in deal for its monkeypox antiviral
Endpoints
SIGA technologies
antivirals
monkeypox
TPOXX
Flag link:
Emergent wraps up purchase of Chimerix's potential monkeypox treatment Tembexa
Emergent wraps up purchase of Chimerix's potential monkeypox treatment Tembexa
Fierce Pharma
Chimerix
monkeypox
Emergent BioSolutions
Tembexa
antivirals
Flag link:
Pardes initiates Phase II trial of Covid-19 antiviral drug
Pardes initiates Phase II trial of Covid-19 antiviral drug
Clinical Trials Arena
Pardes Biosciences
PBI-0451
COVID-19
antivirals
Flag link:
US earmarks up to $680M for Chimerix’s smallpox drug Tembexa, clearing way for Emergent buyout
US earmarks up to $680M for Chimerix’s smallpox drug Tembexa, clearing way for Emergent buyout
Fierce Pharma
Chimerix
monkeypox
Tembexa
government contract
antivirals
Flag link:
Multiple monkeypox vaccine and antiviral trials are launching across the world
Multiple monkeypox vaccine and antiviral trials are launching across the world
Clinical Trials Arena
monkeypox
clinical trials
Bavarian Nordic
vaccines
Jynneos
SIGA technologies
TPOXX
antivirals
Flag link:
Feud between two biotechs left nearly 12M doses of monkeypox antiviral on the table
Feud between two biotechs left nearly 12M doses of monkeypox antiviral on the table
Endpoints
monkeypox
antivirals
SIGA technologies
Chimerix
Flag link:
NanoViricides Reports That It Has Begun Drug Development to Combat Monkeypox Virus
NanoViricides Reports That It Has Begun Drug Development to Combat Monkeypox Virus
BioSpace
NanoViricides
antivirals
monkeypox
drug development
Flag link:
Pfizer's Paxlovid sales will top at $30B this year then fall over time: analysts
Pfizer's Paxlovid sales will top at $30B this year then fall over time: analysts
Fierce Pharma
Pfizer
Paxlovid
antivirals
COVID-19
Flag link:
Staffing shortage could be hindering controversial Paxlovid clearance
Staffing shortage could be hindering controversial Paxlovid clearance
Beckers Hospital Review
Pfizer
Paxlovid
COVID-19
antivirals
FDA
pharmacists
Flag link:
Pages
1
2
3
4
5
6
next ›
last »